Updated international consensus report on the investigation and management of primary immune thrombocytopenia
Over the last decade, there have been numerous developments and changes in treatment
practices for the management of patients with immune thrombocytopenia (ITP). This article is …
practices for the management of patients with immune thrombocytopenia (ITP). This article is …
[HTML][HTML] Immune thrombocytopenia
Key Clinical Points Immune Thrombocytopenia Immune thrombocytopenia (ITP) is
diagnosed in patients with a platelet count below 100,000 per cubic millimeter in whom …
diagnosed in patients with a platelet count below 100,000 per cubic millimeter in whom …
Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the Writing Committee of the American Society for Apheresis: the …
A Padmanabhan, L Connelly‐Smith… - Journal of clinical …, 2019 - Wiley Online Library
ABSTRACT The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating and categorizing …
Special Issue Writing Committee is charged with reviewing, updating and categorizing …
[PDF][PDF] 第五次全国幽门螺杆菌感染处理共识报告
刘文忠， 谢勇， 陆红， 成虹， 曾志荣， 周丽雅， 陈烨… - 中华消化杂志, 2017 - file.medtrib.cn
由中华医学会消化病学分会幽门螺杆菌(Hp) 和消化性溃疡学组主办的“幽门螺杆菌感染处理
maastricht 5 共识研讨会暨第五次全国幽门螺杆菌感染处理共识会” 于2016 年12 月15~ 16 …
maastricht 5 共识研讨会暨第五次全国幽门螺杆菌感染处理共识会” 于2016 年12 月15~ 16 …
Management of Helicobacter pylori infection—the Maastricht V/Florence consensus report
P Malfertheiner, F Mégraud, CA O'Morain, JP Gisbert… - Gut, 2017 - gut.bmj.com
Important progress has been made in the management of Helicobacter pylori infection and
in this fifth edition of the Maastricht Consensus Report, key aspects related to the clinical role …
in this fifth edition of the Maastricht Consensus Report, key aspects related to the clinical role …
Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the writing committee of the American society for apheresis: the …
J Schwartz, A Padmanabhan, N Aqui… - Journal of clinical …, 2016 - Wiley Online Library
The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special
Issue Writing Committee is charged with reviewing, updating, and categorizing indications …
Issue Writing Committee is charged with reviewing, updating, and categorizing indications …
[HTML][HTML] Mycophenolate mofetil for first-line treatment of immune thrombocytopenia
CA Bradbury, J Pell, Q Hill, C Bagot… - … England Journal of …, 2021 - Mass Medical Soc
Background Immune thrombocytopenia is a rare autoimmune disorder with associated
bleeding risk and fatigue. Recommended first-line treatment for immune thrombocytopenia …
bleeding risk and fatigue. Recommended first-line treatment for immune thrombocytopenia …
Update on the use of immunoglobulin in human disease: a review of evidence
EE Perez, JS Orange, F Bonilla, J Chinen… - Journal of Allergy and …, 2017 - Elsevier
Human immunoglobulin preparations for intravenous or subcutaneous administration are
the cornerstone of treatment in patients with primary immunodeficiency diseases affecting …
the cornerstone of treatment in patients with primary immunodeficiency diseases affecting …
Clinical updates in adult immune thrombocytopenia
MP Lambert, TB Gernsheimer - Blood, The Journal of the …, 2017 - ashpublications.org
Immune thrombocytopenia (ITP) occurs in 2 to 4/100 000 adults and results in variable
bleeding symptoms and thrombocytopenia. In the last decade, changes in our …
bleeding symptoms and thrombocytopenia. In the last decade, changes in our …
[HTML][HTML] Recent advances in the mechanisms and treatment of immune thrombocytopenia
Primary immune thrombocytopenia is an autoimmune disease associated with a reduced
peripheral blood platelet count. The phenotype is variable with some patients suffering no …
peripheral blood platelet count. The phenotype is variable with some patients suffering no …